Downregulation of microRNA-211 is involved in expression of preferentially expressed antigen of melanoma in melanoma cells

International Journal of Oncology

Volumn 39, Issue 3, 2011, Pages 665-672

  Sakurai, Eiichi ^a   Maesawa, Chihaya ^a   Shibazaki, Masahiko ^a   Yasuhira, Shinji ^a   Oikawa, Hiroki ^a   Sato, Masayuki ^a   Tsunoda, Kanako ^a   Ishikawa, Yuichi ^a   Watanabe, Ayano ^a   Takahashi, Kazuhiro ^a   Akasaka, Toshihide ^a   Masuda, Tomoyuki ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

Cancer testis antigen; Malignant melanoma; microRNA; miR 211; PRAME

Indexed keywords

LUCIFERASE; MICRORNA; MICRORNA 211; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CELL CULTURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; EMBRYO; ENZYMATIC ASSAY; HUMAN; HUMAN CELL; MELANOCYTE; MELANOMA; MELANOMA CELL; NEWBORN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION;

ANTIGENS, NEOPLASM; CELL LINE, TUMOR; DOWN-REGULATION; HEK293 CELLS; HUMANS; MELANOMA; MICRORNAS; SUBSTRATE SPECIFICITY; TRANSFECTION;

EID: 79959924510     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2011.1084     Document Type: Article

References (39)

1. He L and Hannon GJ: MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 5: 522-531, 2004. (Pubitemid 38868508)
2. Meltzer PS: Cancer genomics: small RNAs with big impacts. Nature 435: 745-746, 2005.
3. Calin GA, Liu CG, Sevignani C, et al: MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc Natl Acad Sci USA 101: 11755-11760, 2004. (Pubitemid 39095368)
4. Ciafre SA, Galardi S, Mangiola A, et al: Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem Biophys Res Commun 334: 1351-1358, 2005. (Pubitemid 41074723)
5. Hayashita Y, Osada H, Tatematsu Y, et al: A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res 65: 9628-9632, 2005. (Pubitemid 41541436)
6. He H, Jazdzewski K, Li W, et al: The role of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad Sci USA 102: 19075-19080, 2005. (Pubitemid 43049568)
7. Iorio MV, Ferracin M, Liu CG, et al: MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65: 7065-7070, 2005. (Pubitemid 41161233)
8. Jiang J, Lee EJ, Gusev Y and Schmittgen TD: Real-time expression profiling of microRNA precursors in human cancer cell lines. Nucleic Acids Res 33: 5394-5403, 2005. (Pubitemid 41548806)
9. Lu J, Getz G, Miska EA, et al: MicroRNA expression profiles classify human cancers. Nature 435: 834-838, 2005. (Pubitemid 40839735)
10. Volinia S, Calin GA, Liu CG, et al: A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 103: 2257-2261, 2006. (Pubitemid 43271657)
11. Yanaihara N, Caplen N, Bowman E, et al: Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9: 189-198, 2006. (Pubitemid 43357945)
12. Bottoni A, Zatelli MC, Ferracin M, et al: Identification of differentially expressed microRNAs by microarray: a possible role for microRNA genes in pituitary adenomas. J Cell Physiol 210: 370-377, 2007. (Pubitemid 44956882)
13. Lee EJ, Gusev Y, Jiang J, et al: Expression profiling identifies microRNA signature in pancreatic cancer. Int J Cancer 120: 1046-1054, 2007. (Pubitemid 46214304)
14. Takamizawa J, Konishi H, Yanagisawa K, et al: Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 64: 3753-3756, 2004. (Pubitemid 38697282)
15. Johnson SM, Grosshans H, Shingara J, et al: RAS is regulated by the let-7 microRNA family. Cell 120: 635-647, 2005. (Pubitemid 40343076)
16. Calin GA, Dumitru CD, Shimizu M, et al: Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 99: 15524-15529, 2002. (Pubitemid 35403967)
17. Cimmino A, Calin GA, Fabbri M, et al: miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci USA 102: 13944-13949, 2005. (Pubitemid 41377683)
18. O'Donnell KA, Wentzel EA, Zeller KI, Dang CV and Mendell JT: c-Myc-regulated microRNAs modulate E2F1 expression. Nature 435: 839-843, 2005. (Pubitemid 40839736)
19. He L, Thomson JM, Hemann MT, et al: A microRNA polycistron as a potential human oncogene. Nature 435: 828-833, 2005. (Pubitemid 40839734)
20. Voorhoeve PM, le Sage C, Schrier M, et al: A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Cell 124 1169-1181, 2006.
21. Saito Y, Liang G, Egger G, et al: Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell 9: 435-443, 2006. (Pubitemid 43832188)
22. Calin GA, Ferracin M, Cimmino A, et al: A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 353: 1793-1801, 2005. (Pubitemid 41549891)
23. Zhang L, Huang J, Yang N, et al: microRNAs exhibit high frequency genomic alterations in human cancer. Proc Natl Acad Sci USA 103: 9136-9141, 2006. (Pubitemid 43902545)
24. Blower PE, Verducci JS, Lin S, et al: MicroRNA expression profiles for the NCI-60 cancer cell panel. Mol Cancer Ther 6: 1483-1491, 2007. (Pubitemid 46954015)
25. Gaur A, Jewell DA, Liang Y, et al: Characterization of microRNA expression levels and their biological correlates in human cancer cell lines. Cancer Res 67: 2456-2468, 2007. (Pubitemid 46548930)
26. Ikeda H, Lethe B, Lehmann F, et al: Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor. Immunity 6: 199-208, 1997. (Pubitemid 27145564)
27. Haqq C, Nosrati M, Sudilovsky D, et al: The gene expression signatures of melanoma progression. Proc Natl Acad Sci USA 102: 6092-6097, 2005. (Pubitemid 40594260)
28. Hoashi T, Kadono T, Kikuchi K, Etoh T and Tamaki K: Differential growth regulation in human melanoma cell lines by TIMP-1 and TIMP-2. Biochem Biophys Res Commun 288: 371-379, 2001. (Pubitemid 33022493)
29. Neumann E, Engelsberg A, Decker J, et al: Heterogeneous expression of the tumor-associated antigens RAGE-1, PRAME, and glycoprotein 75 in human renal cell carcinoma: candidates for T-cell-based immunotherapies? Cancer Res 58: 4090-4095, 1998.
30. Willenbrock K, Kuppers R, Renne C, et al: Common features and differences in the transcriptome of large cell anaplastic lymphoma and classical Hodgkin's lymphoma. Haematologica 91: 596-604, 2006. (Pubitemid 43799453)
31. Li CM, Guo M, Borczuk A, et al: Gene expression in Wilms' tumor mimics the earliest committed stage in the metanephric mesenchymal-epithelial transition. Am J Pathol 160: 2181-2190, 2002. (Pubitemid 34663409)
32. Boon K, Edwards JB, Siu IM, et al: Comparison of medulloblastoma and normal neural transcriptomes identifies a restricted set of activated genes. Oncogene 22: 7687-7694, 2003. (Pubitemid 37464103)
33. Schenk T, Stengel S, Goellner S, Steinbach D and Saluz HP: Hypomethylation of PRAME is responsible for its aberrant overexpression in human malignancies. Genes Chromosomes Cancer 46: 796-804, 2007. (Pubitemid 47106183)
34. Sigalotti L, Fratta E, Coral S, et al: Intratumor heterogeneity of cancer/testis antigens expression in human cutaneous melanoma is methylation-regulated and functionally reverted by 5-aza-2′-deoxycytidine. Cancer Res 64 9167-9171, 2004. (Pubitemid 39665532)
35. Epping MT, Wang L, Edel MJ, Cariee L, Hernandez M and Bernards R: The human tumor antigen PRAME is a dominant repressor of retinoic acid receptor signaling. Cell 122: 835-847, 2005. (Pubitemid 41345202)
36. Rosenthal MA and Oratz R: Phase II clinical trial of recombinant alpha 2b interferon and 13 cis retinoic acid in patients with metastatic melanoma. Am J Clin Oncol 21: 352-354, 1998. (Pubitemid 28366902)
37. Sondak VK, Liu PY, Flaherty LE, et al: A phase II evaluation of all-trans-retinoic acid plus interferon alfa-2a in stage IV melanoma: a Southwest Oncology Group study. Cancer J Sci Am 5: 41-47, 1999. (Pubitemid 29108645)
38. Epping MT and Bernards R: A causal role for the human tumor antigen preferentially expressed antigen of melanoma in cancer. Cancer Res 66: 10639-10642, 2006. (Pubitemid 44876955)
39. Li L, Giannopoulos K, Reinhardt P, et al: Immunotherapy for patients with acute myeloid leukemia using autologous dendritic cells generated from leukemic blasts. Int J Oncol 28: 855-861, 2006.